Cmed Clinical Services has appointed Graham Belgrave as its chief operations officer with a remit to manage the company’s daily clinical operating activities.
He joins the UK-based firm from Grunenthal GmbH where he was senior vice president and global head of clinical development, science and operations.
During his 30 year career in the pharmaceutical industry, Belgrave has held positions at GSK, Pfizer and Vernalis as well as working in consultancy and interim management positions, including for Roche’s oncology portfolio.
Dr David Connelly, Cmed’s chief executive officer, said: “Graham has a great track record over many years in the pharmaceutical industry and his breadth of clinical development experience across many therapy areas in phases I-IV combined with his strong leadership skills will complement and strengthen our existing senior management team.
“He will be a valuable asset to Cmed as we continue to drive growth.”